News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Sponsor & Foundation News

APDA Establishes Research Fund in Memory of Joel Gerstel

Dementia Drug May Improve Gait in Parkinson's Patients

Acorda Therapeutics to Acquire Biotie Therapies

Participants Invited to Take Survey on Cognition and Parkinsonís Disease

Adamas Announces Positive Phase 3 Results for Treatment of Levodopa-induced Dyskinesia in Patients With PD

UCB Trials Wearable Sensor for Parkinson's Disease

Biogen Enters Collaboration with the Parkinsonís Institute and Clinical Center

Parkinsonís Institute and Clinical Center Publishes a Review on the State of Parkinsonís Research in Nature Genetics

Acorda Therapeutics Supports the National Disability Instituteís Financial Wellness Webinar Series

Podcast Focusing on Cultivating Patience for Well Being in Parkinson's Disease

The Parkinson Alliance Survey Reports a Relationship Between Patience and Well-Being in Parkinsonís Disease

NPFís Medical Director Publishes New Book on Breakthrough Therapies for PD

INTREPID Clinical Trial for DBS Continues Recruitment

Participants Invited to Take Survey on Nutrition and Parkinsonís Disease

The Michael J. Fox Foundation and Imago Pharmaceuticals Partner to Speed Parkinson's Research

Adamas Pharmaceuticals Issued Patent

Participants Invited to Take Survey on Patience and Well-Being in Parkinsonís Disease

Adamas Pharmaceuticals' Phase 2/3 Clinical Study Published in Movement Disorders

UCB and Neuropore Enter Into World-Wide Collaboration and Agreement

U.S. FDA Approves AbbVieís DUOPAô Enteral Suspension for Treatment of Advanced PD

Autonomic Dysfunction in Parkinsonís Disease With and Without Deep Brain Stimulation

CE Mark for Boston Scientificís Verciseô DBS System for Treating Tremors

Teva Recalls Generic Parkinsonís Drug

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUDô

back to top